CN101700334B - Chinese herbal preparation for treating prostatic hypertrophy - Google Patents
Chinese herbal preparation for treating prostatic hypertrophy Download PDFInfo
- Publication number
- CN101700334B CN101700334B CN2009102300368A CN200910230036A CN101700334B CN 101700334 B CN101700334 B CN 101700334B CN 2009102300368 A CN2009102300368 A CN 2009102300368A CN 200910230036 A CN200910230036 A CN 200910230036A CN 101700334 B CN101700334 B CN 101700334B
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese herbal
- herbal preparation
- radix
- chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title abstract description 9
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 title abstract description 7
- 208000004403 Prostatic Hyperplasia Diseases 0.000 title abstract description 6
- 201000004240 prostatic hypertrophy Diseases 0.000 title abstract 2
- 241000206469 Pulsatilla Species 0.000 claims abstract description 4
- 210000002307 prostate Anatomy 0.000 claims description 15
- 206010020718 hyperplasia Diseases 0.000 claims description 11
- 210000000582 semen Anatomy 0.000 claims description 10
- 239000002994 raw material Substances 0.000 claims description 5
- 241000545442 Radix Species 0.000 claims description 3
- 229940126680 traditional chinese medicines Drugs 0.000 claims description 2
- 241000202755 Areca Species 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 20
- 210000004369 blood Anatomy 0.000 abstract description 20
- 239000003814 drug Substances 0.000 abstract description 19
- 230000000694 effects Effects 0.000 abstract description 9
- 208000002193 Pain Diseases 0.000 abstract description 8
- 238000003745 diagnosis Methods 0.000 abstract description 6
- 230000027939 micturition Effects 0.000 abstract description 6
- 244000080767 Areca catechu Species 0.000 abstract description 3
- 239000009636 Huang Qi Substances 0.000 abstract description 3
- 241000427159 Achyranthes Species 0.000 abstract 1
- 241000049624 Alisma plantago-aquatica subsp. orientale Species 0.000 abstract 1
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 235000006226 Areca catechu Nutrition 0.000 abstract 1
- 239000003390 Chinese drug Substances 0.000 abstract 1
- 244000192528 Chrysanthemum parthenium Species 0.000 abstract 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 210000002700 urine Anatomy 0.000 description 12
- 208000024891 symptom Diseases 0.000 description 10
- 230000001737 promoting effect Effects 0.000 description 9
- 208000004880 Polyuria Diseases 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 7
- 230000035619 diuresis Effects 0.000 description 7
- 206010013990 dysuria Diseases 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 239000012567 medical material Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 229940079593 drug Drugs 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 230000001047 pyretic effect Effects 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010036018 Pollakiuria Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 229940071462 oralone Drugs 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- RNYZJZKPGHQTJR-UHFFFAOYSA-N protoanemonin Chemical compound C=C1OC(=O)C=C1 RNYZJZKPGHQTJR-UHFFFAOYSA-N 0.000 description 2
- 239000009806 pulsatillae Substances 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 201000002327 urinary tract obstruction Diseases 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 241000213006 Angelica dahurica Species 0.000 description 1
- 201000003126 Anuria Diseases 0.000 description 1
- 208000012639 Balance disease Diseases 0.000 description 1
- 206010013647 Drowning Diseases 0.000 description 1
- 235000005206 Hibiscus Nutrition 0.000 description 1
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 1
- 244000048199 Hibiscus mutabilis Species 0.000 description 1
- 235000003973 Hibiscus mutabilis Nutrition 0.000 description 1
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 208000007074 Trichomonas Vaginitis Diseases 0.000 description 1
- 208000025206 Trichomonas vaginitis urogenital infection Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 231100000880 dysequilibrium Toxicity 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000000745 gonadal hormone Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 210000000088 lip Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 208000030212 nutrition disease Diseases 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000009666 routine test Methods 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese herbal preparation for treating prostatic hypertrophy, which is prepared from the following Chinese drugs in parts by weight: 30 parts of achyranthes, 30 parts of motherwort, 20 parts of peach kernel, 20 parts of salvia miltiorrhiza, 20 parts of radix astragali, 30 parts of alisma orientale, 20 parts of Chinese Pulsatilla root, 30 parts of hedyotic diffusa, 20 parts of angelica, 15 parts of betelnut and 20 parts of dandelion. The Chinese herbal preparation has the efficacies of dispersing blood stasis to eliminate stagnation, benefiting micturition and disintoxicating. The Chinese herbal preparation is developed on the basis of diagnosis and treatment of the traditional medicine in combination with modern achievements in scientific research, and has the characteristics of specific curative effect, high safety and convenience, no toxic or side effect, high cure rate, no pain and low price.
Description
Technical field
The invention belongs to field of traditional Chinese, particularly a kind of Chinese medicine preparation of treating prostate hyperplasia.
Background technology
Prostate hyperplasia is also claimed benign prostatic hyperplasia; Be the modal benign tumor of human male, past attempts is called benign prostatauxe, has been included into benign tumor at present; The traditional Chinese medical science is referred to as the difficulty in urination; In Ming Dynasty's building cottonrose hibiscus it " medical detailed outline " institute say " constipation and anuria one of closes disease also, branchs, sudden and violent of a specified duration very.The lid person of closing sudden serious illness is closed for drowning, and drop does not go out, and popular name urinary obstruction is also, infirmity person's prolonged illness, the dripping drop of difficult unination symptom-complex and go out tens of times on the one." sickness rate increases progressively with the age, but when the hypertrophy pathological changes is arranged, clinical symptoms is arranged not necessarily.External one group of 206 example male postmortem person more than 40 years old, 80.1% has prostatic hyperplasia, and 67 philtrums more than 80 years old account for 90.5%, and the treatment of hyperplasia of prostate has become the important topic in person in middle and old age's medical science in a word.
The prostate local inflammation of the generation of primary disease and person in middle and old age's gonadal hormone dysequilibrium, prolonged and repeated outbreak, and Nutrition and Metabolism disorder etc. relevant.The traditional Chinese medical science thinks to be because of insufficiency of the spleen deficiency of the kidney, and wet knot holds knot, loses smart the silt and stops in turbid and cause assertive evidence.
The classical symptom of primary disease is frequent micturition, dysuria, hematuria and urine retention etc., can make through symptom, health check-up and lab testing clinically and clarifying a diagnosis.
The traditional Chinese medical science can be divided into damp invasion of lower energizer clinically, suffer from a deficiency of the kidney and disease type Coryza Treated by Syndrome Differentiation such as blood stasis obstruction, obtained very good effect,
Invent a kind of not only safety but also effective Chinese medicine preparation, be significant.
Summary of the invention
Technical problem to be solved by this invention provides a kind of Chinese medicine preparation of treating prostate hyperplasia, has determined curative effect, safe ready, has no side effect, cure rate height, no pain, characteristics that the medicine valency is cheap.
The Chinese medicine preparation of a kind of treatment of the present invention prostate hyperplasia is characterized in that being processed by following parts by weight of traditional Chinese medicines raw material: 20 parts of 30 parts of Radix Achyranthis Bidentataes, 30 parts of Herba Leonuris, 20 parts in Semen Persicae, 20 parts of Radix Salviae Miltiorrhizaes, 20 parts of the Radixs Astragali, 30 parts of Rhizoma Alismatis, 20 parts of the Radix Pulsatillaes, 30 parts of Herba Hedyotidis Diffusaes, 20 parts of Radix Angelicae Sinensis, 15 parts of Semen Arecaes and Herba Taraxacis.
Method for preparing is got that above-mentioned raw materials is cleaned, roguing, is dried, is ground into granule, soaks 1 hour; Put and add the decocting secondary in the multi-function extractor, the decocting of 10 times of weight of totalling medical material boiled 1.5-2 hour for the first time, got decocting liquid and filtered; The decocting of 7 times of weight of totalling medical material boiled 1-1.5 hour for the second time, got the decocting liquid hybrid filtering twice, in the heat-sealing bag; 105 ℃ of high temperature sterilizes, packing promptly gets.The decoction of the treatment prostate hyperplasia that the present invention processes is that plastics are packed, every bag of 210mil, oral one time one bag, every day secondary, one month is a course of treatment.
Pharmacology analysis:
Radix Achyranthis Bidentatae promoting blood circulation to restore menstrual flow, invigorating the liver and kidney, relieving stranguria by diuresis.Descending, the promoting blood circulation to restore menstrual flow of its property of these article is usually used in pyretic stranguria stranguria with blood sand Stranguria etc. clinically.
Herba Leonuri promoting blood flow to regulate menstruation, inducing diuresis to remove edema not only are apt to control amenorrhea due to stagnation of blood clinically, and can harness the river again swollen and dysuria have the merit of clearing heat, releasing toxin, removing swelling.
Semen Persicae blood circulation promoting and blood stasis dispelling, loosening bowel to relieve constipation.Be used for multiple congestion clinically, these article bitter in the mouth and go into the conscience blood system is kindly let out stasis, and blood stasis dispelling power is stronger, claims stasis-breaking drug again.
Radix Salviae Miltiorrhizae promoting blood flow to regulate menstruation, removing heat from blood eliminating carbuncle are calmed the nerves.These article are usually used in the ambition of blood stasis, epigastric pain and gather, arthromyodynia etc., be the key medicine of blood circulation promoting and blood stasis dispelling, be widely used in various congestion.
Radix Astragali tonifying Qi and lifting yang, inducing diuresis to remove edema, holder skin ulcer granulation promoting is usually used in the wet dysuria that loses fortune of deficiency of spleen-QI and stomach-QI and deficiency of vital energy water, edema, can QI invigorating again can diuresis.
The Rhizoma Alismatis promoting diuresis to eliminate damp pathogen, expel the heat-evil, be used for edema, dysuria.These article are light to be oozed, and its diuretic effect is better than Poria, so be usually used in damp-heat in lower-JIAO.
Radix Pulsatillae heat-clearing and toxic substances removing, eliminating pathogenic heat from blood to cure dysentery, these article are apt to damp and hot, the noxious heat in the blood system of clearing stomach intestinal.These article contain protoanemonin, Saponin, to staphylococcus aureus, bacillus pyocyaneus, Bacillus typhi, Salmonella, tangible antibacterial action are arranged, and these article have tangible killing action to trichomonas vaginitis.
The Herba Hedyotidis Diffusae heat-clearing and toxic substances removing, inducing diuresis for treating stranguria syndrome.Be usually used in the puckery pain of pyretic stranguria clinically.
The Herba Taraxaci heat-clearing and toxic substances removing, the eliminating carbuncle eliminating stagnation, dampness removing is treating stranguria.These article are usually used in carbuncle and treat poison, the wet carbuncle of pyretic stranguria.These article of it is reported have stronger inhibitory action to staphylococcus aureus, Hemolytic streptococcus.
Chinese angelica blood supplementing, invigorate blood circulation, collateral dredging, pain relieving, intestine moistening.These article blood deficiency can be mended, stasis can be led to, blood is dry can moisten, and is referred to as the panacea in the blood.
Semen Arecae parasite killing, removing food stagnancy, promoting the circulation of QI to induce diuresis.
The present invention follows the principles of formulating prescriptions of the traditional Chinese medical science " monarch "; Use Radix Achyranthis Bidentatae, Herba Leonuri, Semen Persicae, Radix Salviae Miltiorrhizae to be monarch drug, the Radix Astragali, Radix Angelicae Sinensis, Rhizoma Alismatis, Semen Arecae are ministerial drug, and the Radix Pulsatillae, Herba Hedyotidis Diffusae, Herba Taraxaci are adjuvant; All medicine phases 5; Blood stasis-eliminating and stagnation-dissipating, tonneau water channel, assistant be with the antidotal effect, and the treatment prostate hyperplasia has determined curative effect, safe ready, has no side effect, cure rate height, no pain, characteristics that the medicine valency is cheap.
Curative effect is judged:
(1) cures: symptoms such as no frequent micturition, dysuria, hematuria, urine retention; Lab testing does not have resembling of serum creatinine, non-protein nitrogen and blood urea nitrogen rising, and the ultrasound diagnosis prostate is normal; Whole body depletion of YANG gonosome Zheng Kecha.
(2) take a turn for the better: symptoms such as frequent micturition, dysuria, urine retention obviously alleviate, and the random thoughts bradyuria is unable, and it is lasting to occur sometimes urinating, and time lengthening is not urinated but generally do not influence; Chemical examination: the visible blood urea nitrogen of idol raises; Rectal touch: outgrowth prostate obviously reduces.
(3) invalid: various symptoms do not have improvement.
The result: treatment prostate hyperplasia patient 50 examples, take decoction of the present invention, each one bag, a twice-daily, take half an hour ante cibum; One month is a course of treatment, take continuously 3 the course of treatment observe the curative effect: 37 examples of fully recovering, account for 74%, 10 examples take a turn for the better; Account for 20%, invalid 3 examples account for 6%, total effective rate 94%.After three course of therapy, patient does not have any untoward reaction, and three big routine tests and hepatic and renal function detection, Electrocardioscopy etc. are no abnormal.
Below enumerate several model cases:
Case 1, patient Zhai so-and-so, man, 70 years old; In mid-June, 2006, head examined, and the patient is not smooth because of urine, and dysuria is had a surplus existing February; Once be prostate hyperplasia (II degree) at local people's hospital diagnosis April, because of compelled row urethral catheterization after the urinary obstruction, retention catheterization bag; Symptomatic treatment, no any effect after February is in here diagnosis and treatment in June.History of present illness, the urine of patient's unknown reason before February is not smooth, and the urine line attenuates, sometimes urine drop and descend lower abdomen contracture distending pain; Looking into the tongue fur purple secretly examines and is qi stagnation and blood stasis type.Oral medicine of the present invention is after 20 days, and the self-induction lower abdominal distention pain obviously alleviates, and in urethra, overflows a spot of urine sometimes; After continuing to take 20 days, come institute's check, urine was often flowed out over 5 days in the main suit in urethral orifice; After extracting urinary catheter out; The patient is defecation independently, but the urine line is still thin, and suggestion continued clothes 20 days; The patient takes medicine of the present invention after 2 courses of treatment, and symptom is improved fully, and urine is normal.The ultrasound diagnosis prostate has returned to normal value.Follow up a case by regular visits to and do not have recurrence in 2 years.
Case 2, patient neat so-and-so, 60 years old, in August, 2005, head examined; The main suit is because of frequency of micturition; It is not smooth to urinate, and once is diagnosed as prostatic hyperplasia, the enlargement of I degree before half a year in the People's Hospital, Zibo City, and its effects such as the oral a large amount of Western medicine in back, Chinese medicine, folk prescription are very little; And subjective symptoms increases the weight of day by day, so my institute of going to a doctor in August, 2005.Main suit's frequency of micturition, it is not smooth to urinate, drop in the time of very and descending, yellowish urine, urgent micturition, self-induction is scorching hot, burning pain sometimes, bitter taste, vexed, in time, be hard and dry; Look into yellowish fur, examine and be prostatic hyperplasia (damp heat downward flowing type).Oral medicine of the present invention is after 2 courses of treatment, the symptom complete obiteration, the inspection of each items such as B ultrasonic chemical examination is all normal, after follow up a case by regular visits to 2 years no abnormality seens.
The specific embodiment
The umber of each raw material of Chinese medicine of following examples is weight portion.
Embodiment: 20 parts of 30 parts of Radix Achyranthis Bidentataes, 30 parts of Herba Leonuris, 20 parts in Semen Persicae, 20 parts of Radix Salviae Miltiorrhizaes, 20 parts of the Radixs Astragali, 30 parts of Rhizoma Alismatis, 20 parts of the Radix Pulsatillaes, 30 parts of Herba Hedyotidis Diffusaes, 20 parts of Radix Angelicae Sinensis, 15 parts of Semen Arecaes and Herba Taraxacis.
Method for preparing is got that above-mentioned raw materials is cleaned, roguing, is dried, is ground into granule, soaks 1 hour; Put and add the decocting secondary in the multi-function extractor, the decocting of 10 times of weight of totalling medical material boiled 1.5-2 hour for the first time, got decocting liquid and filtered; The decocting of 7 times of amounts of totalling medical material boiled 1-1.5 hour for the second time, got the decocting liquid hybrid filtering twice, in the heat-sealing bag; 105 ℃ of high temperature sterilizes, packing promptly gets.The decoction of the treatment prostate hyperplasia that the present invention processes is that plastics are packed, every bag of 210mil, oral one time one bag, every day secondary, one month is a course of treatment.
Claims (1)
1. decoction of treating prostate hyperplasia is characterized in that being processed by following parts by weight of traditional Chinese medicines raw material: 20 parts of 30 parts of Radix Achyranthis Bidentataes, 30 parts of Herba Leonuris, 20 parts in Semen Persicae, 20 parts of Radix Salviae Miltiorrhizaes, 20 parts of the Radixs Astragali, 30 parts of Rhizoma Alismatis, 20 parts of the Radix Pulsatillaes, 30 parts of Herba Hedyotidis Diffusaes, 20 parts of Radix Angelicae Sinensis, 15 parts of Semen Arecaes and Herba Taraxacis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102300368A CN101700334B (en) | 2009-11-11 | 2009-11-11 | Chinese herbal preparation for treating prostatic hypertrophy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102300368A CN101700334B (en) | 2009-11-11 | 2009-11-11 | Chinese herbal preparation for treating prostatic hypertrophy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101700334A CN101700334A (en) | 2010-05-05 |
| CN101700334B true CN101700334B (en) | 2012-02-08 |
Family
ID=42155278
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009102300368A Expired - Fee Related CN101700334B (en) | 2009-11-11 | 2009-11-11 | Chinese herbal preparation for treating prostatic hypertrophy |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101700334B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104027594A (en) * | 2014-05-26 | 2014-09-10 | 烟台瑞智生物医药科技有限公司 | Traditional Chinese medicine for treating blood stasis interior obstruction type dysuria |
-
2009
- 2009-11-11 CN CN2009102300368A patent/CN101700334B/en not_active Expired - Fee Related
Non-Patent Citations (1)
| Title |
|---|
| 中华中医药学会糖尿病分会.中医肾病学科.《中医学与中药学学科发展报告（2006）》.2006,100-148. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101700334A (en) | 2010-05-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101912593B (en) | Medicament for treating dysmenorrheal and preparation method thereof | |
| CN102247585A (en) | Chinese medicinal composition for treating rheumatism, preparation thereof and preparation method thereof | |
| CN101961479A (en) | Chinese medicinal composition for treating bellyache and preparation method thereof | |
| CN103432477A (en) | Gout treatment traditional Chinese medicine preparation | |
| CN102228603B (en) | Chinese medicine for treating retention of urine | |
| CN102688420B (en) | Traditional Chinese medicine decoction for treating psoriasis | |
| CN102000164B (en) | Traditional Chinese medicine composition for treating psoriasis and preparation method thereof | |
| CN102727736A (en) | Constipation treating medicine | |
| CN102058715A (en) | Chinese medicine preparation for treating chronic prostatitis and preparation method thereof | |
| CN101274075A (en) | Chinese medicine for curing uremia | |
| CN103656377B (en) | A kind of Chinese medicine of internal and external application chronic prostatitis | |
| CN104940760A (en) | Four compositions for preventing and treating acute epidemic disease and preparation processes thereof | |
| CN101700334B (en) | Chinese herbal preparation for treating prostatic hypertrophy | |
| CN102210814A (en) | Chinese medicinal composition for treating chronic prostatitis and preparation method thereof | |
| CN100388931C (en) | Medicine for treating pelvic inflammation and preparation method thereof | |
| CN102895444A (en) | Traditional Chinese medicine composition for treating lithangiuria | |
| CN102784378A (en) | Traditional Chinese medicine preparation for treating sub-health | |
| CN102139080A (en) | Chinese medicinal composition for treating chronic gastritis and peptic ulcer and preparation method thereof | |
| CN102188643B (en) | Medicament for treating damp-heat blockage syndrome and its preparation method | |
| CN103110756B (en) | Traditional Chinese medicine composition for treating renal hematuria | |
| CN105233056A (en) | Rhubarb oral liquid capable of clearing away heat and removing dampness and beneficial to choleresis and detoxification and preparation method of rhubarb oral liquid | |
| CN101879266A (en) | Method for preparing Chinese medicinal lotion for treating infantile rectocele | |
| CN101700335B (en) | Traditional Chinese medicinal preparation for treating chronic appendicitis | |
| CN100540033C (en) | External health care product for hepatitis B rehabilitation and preparation method thereof | |
| CN106728060A (en) | It is a kind of to treat externally applied ointment of rheumatism and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: NANTONG ZHONGNAN TEXTILE CO., LTD. Free format text: FORMER OWNER: SONG AIMIN Effective date: 20131213 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 256100 ZIBO, SHANDONG PROVINCE TO: 226000 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20131213 Address after: 226000, No. 189, Tang Zhabei street, Gangzha District, Jiangsu, Nantong Patentee after: Nantong Zhongnan Textile Co., Ltd. Address before: 256100 Yiyuan County People's Hospital, 21 Shengli Road, Yiyuan, Shandong, Zibo Patentee before: Song Aimin |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20180917 Address after: 226000 639 north outer ring road, Nantong, Jiangsu Patentee after: NANTONG BEICHENG SCIENCE & TECHNOLOGY ENTREPRENEURIAL MANAGEMENT CO., LTD. Address before: 226000 No. 189 Zhabei city street, Gangzha District, Nantong, Jiangsu. Patentee before: Nantong Zhongnan Textile Co., Ltd. |
|
| TR01 | Transfer of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120208 Termination date: 20201111 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |